Targeted therapy with phosphodiesterase 5 inhibitors in patients with pulmonary hypertension due to heart failure and elevated pulmonary vascular resistance: a systematic review
Author:
Affiliation:
1. University of Nebraska Medical CenterOmahaNEUSA
Publisher
Wiley
Subject
Pulmonary and Respiratory Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1177/2045894020948780
Reference32 articles.
1. Pulmonary hypertension due to left heart diseases;Vachiery JL;J Am Coll Cardiol,2013
2. Left ventricular heart failure and pulmonary hypertension;Rosenkranz S;Eur Heart J,2016
3. Association between hemodynamic markers of pulmonary hypertension and outcomes in heart failure with preserved ejection fraction;Vanderpool RR;JAMA Cardiol,2018
4. Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy;Abramson SV;Ann Intern Med,1992
5. Pulmonary hypertension due to left heart disease;Vachiery JL;Eur Respir J,2019
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Inhibidores de la fosfodiesterasa 5 para el tratamiento de la insuficiencia cardiaca: revisión sistemática y metaanálisis de ensayos clínicos aleatorizados;Archivos de Cardiología de México;2024-07-17
2. Correlation between Levels of Serum Lipoprotein-Associated Phospholipase A2 and Soluble Suppression of Tumorigenicity 2 and Condition of Acute Heart Failure Patients and Their Predictive Value for Prognosis;Journal of Healthcare Engineering;2021-12-16
3. Pulmonary vasodilator treatment in pulmonary hypertension due to left heart or lung disease: time for a high‐definition picture?;Pulmonary Circulation;2021-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3